Crosstalk between histone/DNA modifications and RNA N6-methyladenosine modification

被引:3
|
作者
Wang, Yushuai [1 ]
Huang, Huilin [2 ]
Chen, Jianjun [3 ,4 ]
Weng, Hengyou [1 ,5 ,6 ]
机构
[1] Guangzhou Natl Lab, Guangzhou 510005, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
[3] Beckman Res Inst City Hope, Dept Syst Biol, Monrovia, CA 91016 USA
[4] Comprehensive Canc Ctr City Hope, Gehr Family Ctr Leukemia Res & City Hope Comprehen, Duarte, CA 91010 USA
[5] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou 510005, Peoples R China
[6] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou 510120, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金; 美国国家卫生研究院;
关键词
GENE-EXPRESSION; N-6-METHYLADENOSINE RNA; M(6)A RNA; STRUCTURAL BASIS; NUCLEAR-RNA; METHYLATION; CHROMATIN; METABOLISM; RECOGNITION; TRANSLATION;
D O I
10.1016/j.gde.2024.102205
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
N6-methyladenosine 6-methyladenosine (m6A) 6 A) is the most prevalent internal RNA modification in eukaryotic messenger RNAs (mRNAs), regulating gene expression at the transcription and post- transcription levels. Complex interplay between m6A 6 A and other well-studied epigenetic modifications, including histone modifications and DNA modification, has been extensively reported in recent years. The crosstalk between RNA m6A 6 A modification and histone/DNA modifications plays a critical role in establishing the chromatin state for the precise and specific fine-tuning of gene expression and undoubtedly has profound impacts on both physiological and pathological processes. In this review, we discuss the crosstalk between RNA m6A 6 A modification and histone/DNA modifications, emphasizing their sophisticated communications and the mechanisms underlying to gain a comprehensive view of the biological relevance of m6A-based 6 A-based epigenetic network.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
    Wang, Chao-Yung
    Lin, Mei-Hsiu
    Su, Hui-Ting
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (118):
  • [42] N6-methyladenosine RNA modifications: a potential therapeutic target for AML
    Hu, Rong
    Liao, Peiyun
    Xu, Binyan
    Qiu, Yingqi
    Zhang, Honghao
    Li, Yuhua
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2601 - 2612
  • [43] Patterns of N6-Methyladenosine RNA Modifications in the Progression Disease in Glioblastoma
    Fernandes, G.
    Wang, W.
    Peng, J.
    Giglio, P.
    Venere, M.
    Otero, J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 501 - 501
  • [44] The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
    Xu, Xiaoxin
    Zhao, Jiayao
    Yang, Mingyue
    Han, Lutuo
    Yuan, Xingxing
    Chi, Wencheng
    Jiang, Jiakang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [45] The Roles of RNA N6-methyladenosine Modifications in Systemic Lupus Erythematosus
    Xia, Xin
    Qu, Rui
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (04) : 3223 - 3234
  • [46] The involvement of RNA N6-methyladenosine and histone methylation modification in decidualization and endometriosis-associated infertility
    Lin, Xiang
    Dai, Yongdong
    Gu, Weijia
    Zhang, Yi
    Zhuo, Feng
    Zhao, Fanxuan
    Jin, Xiaoying
    Li, Chao
    Huang, Dong
    Tong, Xiaomei
    Zhang, Songying
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (02):
  • [47] Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer
    Huang, Xin
    Guo, Haoyu
    Wang, Lutong
    Yang, Lingkai
    Shao, Zengwu
    Zhang, Weiyue
    MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 27 : 947 - 955
  • [48] Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
    Li, Yu
    Zhang, Xiao-Ming
    Luan, Mei-Wei
    Xing, Jian-Feng
    Chen, Jianguo
    Xie, Shang-Qian
    FRONTIERS IN GENETICS, 2020, 11
  • [49] The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
    Hu, Xiaoge
    Lei, Xiangxiang
    Guo, Jinhui
    Fu, Wen
    Sun, Wen
    Lu, Qiliang
    Su, Wei
    Xu, Qiuran
    Tu, Kangsheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification
    Sun, Xinyu
    Wang, Huirong
    Pu, Xi
    Wu, Yuting
    Yuan, Xiao
    Wang, Xu
    Lu, Hanqiang
    CANCER GENE THERAPY, 2024, 31 (09) : 1315 - 1322